Cargando…

Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials

We aimed to assess the impact of L-carnitine on plasma Lp(a) concentrations through systematic review and meta-analysis of available RCTs. The literature search included selected databases up to 31(st) January 2015. Meta-analysis was performed using fixed-effects or random-effect model according to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serban, Maria-Corina, Sahebkar, Amirhossein, Mikhailidis, Dimitri P., Toth, Peter P., Jones, Steven R., Muntner, Paul, Blaha, Michael J., Andrica, Florina, Martin, Seth S., Borza, Claudia, Lip, Gregory Y. H., Ray, Kausik K., Rysz, Jacek, Hazen, Stanley L., Banach, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709689/ https://www.ncbi.nlm.nih.gov/pubmed/26754058 http://dx.doi.org/10.1038/srep19188

Ejemplares similares

Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Serban, Maria‐Corina, et al.
Publicado: (2016)

Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies
por: Banach, Maciej, et al.
Publicado: (2015)

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Rysz-Górzynska, Magdalena, et al.
Publicado: (2016)

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015)

The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

CETP inhibition in the REVEAL trial: could we aim higher?
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

Erythropoietin update 2011
por: Kowalczyk, Mariusz, et al.
Publicado: (2011)

A systematic review and meta-analysis of clinical trials investigating the effects of flaxseed supplementation on plasma C-reactive protein concentrations
por: Ursoniu, Sorin, et al.
Publicado: (2018)

The mechanisms of atrial fibrillation in hyperthyroidism
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2009)

Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials
por: Broncel, Marlena, et al.
Publicado: (2015)

Dysfunctional high-density lipoprotein: not only quantity but first of all quality?
por: Agouridis, Aris P., et al.
Publicado: (2015)

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions
por: Penson, Peter E., et al.
Publicado: (2018)

Prevalence of statin intolerance: a meta-analysis( )
por: Bytyçi, Ibadete, et al.
Publicado: (2022)

Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials
por: Ursoniu, Sorin, et al.
Publicado: (2015)

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2013)

Blood Pressure Levels and Stroke: J-curve Phenomenon?
por: Malyszko, Jolanta, et al.
Publicado: (2013)

Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans
por: Mazidi, Mohsen, et al.
Publicado: (2017)

Cardiotoxicity of anthracycline therapy: current perspectives
por: Valcovici, Mihaela, et al.
Publicado: (2016)

Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)
por: Banach, Maciej, et al.
Publicado: (2022)

The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review
por: Maierean, Serban, et al.
Publicado: (2017)

Effect of L-carnitine Supplementation on Circulating C-reactive Protein Levels: A Systematic Review and Meta-Analysis
por: Sahebkar, Amirhossein
Publicado: (2015)

Lipids, blood pressure and kidney update 2015
por: Banach, Maciej, et al.
Publicado: (2015)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2020)

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
por: Banach, Maciej, et al.
Publicado: (2015)

Lipid, blood pressure and kidney update 2013
por: Banach, Maciej, et al.
Publicado: (2014)

More Good News on Statins and COVID-19
por: Katsiki, Niki, et al.
Publicado: (2021)

Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!
por: Katsiki, Niki, et al.
Publicado: (2019)

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
por: Katsiki, Niki, et al.
Publicado: (2020)

Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands!
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosis
por: Ganjali, Shiva, et al.
Publicado: (2021)

Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016)

An in vitro investigation of the effects of urolithins A and B on low-density lipoprotein uptake and its regulatory genes
por: Ganjali, Shiva, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2020)

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
por: Cicero, Arrigo F.G., et al.
Publicado: (2017)

Accuracy of low-density lipoprotein cholesterol estimation at very low levels
por: Quispe, Renato, et al.
Publicado: (2017)

Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials
por: Simental-Mendía, Luis E., et al.
Publicado: (2019)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?
por: Anagnostis, Panagiotis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l8q29me16urd2br9rqjqut5bh0